Immuno-Gene Therapeutics In Hematological Cancers: How Science Drives Study Strategy
Source: Premier Research
This webinar reviews the current state of technology in gene therapeutics and examines trends in immuno-oncology and gene therapy for hematological malignancies. Topics include:
- Ingredients for successful study planning and delivery
- Operationalizing studies to achieve conclusive data outcomes
- Data-driven approach to choosing the right sites in the right countries
- Key drivers to retaining patients and meeting study endpoints
- Exploring future trajectories in outsourcing models for innovative biotech companies
Speakers: Luke Gill, Executive Director, Oncology, Strategic Development, Premier Research and Colin Hayward, Chief Medical Officer, Premier Research
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Premier Research
This website uses cookies to ensure you get the best experience on our website. Learn more